Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid.

× No keyword cloud information.

22 in total

1. The inhibition of isoniazid inactivation by means of PAS and benzoyl-PAS in man.

Authors: H LAUENER; G FAVEZ
Journal: Am Rev Respir Dis Date: 1959-07

2. ENZYMES AND DRUG SENSITIVITY. ACETYLATION POLYMORPHISMS.

Authors: D A EVANS
Journal: Proc R Soc Med Date: 1964-06

3. GENETICS OF ISONIAZID METABOLISM IN CAUCASIAN, NEGRO, AND JAPANESE POPULATIONS.

Authors: A P DUFOUR; R A KNIGHT; H W HARRIS
Journal: Science Date: 1964-07-24 Impact factor: 47.728

4. ASPECTS OF THE METABOLISM OF ISONIAZID AND ACETYLISONIAZID IN THE HUMAN AND THE DOG.

Authors: A S YARD; H MCKENNIS
Journal: J Med Pharm Chem Date: 1962-01

5. STUDIES OF GENETICALLY CONTROLLED SULFADIAZINE ACETYLATION IN RABBIT LIVERS: POSSIBLE IDENTIFICATION OF THE HETEROZYGOUS TRAIT.

Authors: J W FRYMOYER; R F JACOX
Journal: J Lab Clin Med Date: 1963-12

6. THE RELATIONSHIP BETWEEN THE CAPACITIES OF HUMAN SUBJECTS TO ACETYLATE ISONIAZID, SULFANILAMIDE AND SULFAMETHAZINE.

Authors: J H PETERS; G R GORDON; P BROWN
Journal: Life Sci (1962) Date: 1965-01

7. A study of the renal clearances, metabolic inactivation rates, and serum fall-off interaction of isoniazid and paraminosalicylic acid in man.

Authors: J W JENNE; F M MACDONALD; E MENDOZA
Journal: Am Rev Respir Dis Date: 1961-09

8. Studies of human patterns of isoniazid metabolism using an intravenous fall-off technique with a chemical method.

Authors: J W JENNE
Journal: Am Rev Respir Dis Date: 1960-01

9. Kinetic considerations in pharmacogenetic studies of drug metabolism.

Authors: E Nelson
Journal: Life Sci Date: 1965-05 Impact factor: 5.037

10. The inhibition of sulphanilamide acetylation by aromatic and heterocyclic carboxamides and carboxhydrazides.

Authors: W J JOHNSON
Journal: Can J Biochem Physiol Date: 1955-03

26 in total

1. Pharmacokinetics of isoniazid and some metabolites in man.

Authors: H G Boxenbaum; S Riegelman
Journal: J Pharmacokinet Biopharm Date: 1976-08

2. Pharmacokinetics of isoniazid metabolism in man.

Authors: G A Ellard; P T Gammon
Journal: J Pharmacokinet Biopharm Date: 1976-04

3. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.

Authors: D M Grant; K Mörike; M Eichelbaum; U A Meyer
Journal: J Clin Invest Date: 1990-03 Impact factor: 14.808

4. Expression of arylamine N-acetyltransferase in human intestine.

Authors: D Hickman; J Pope; S D Patil; G Fakis; V Smelt; L A Stanley; M Payton; J D Unadkat; E Sim
Journal: Gut Date: 1998-03 Impact factor: 23.059

Review 5. Disease and acetylation polymorphism.

Authors: P K Lunde; K Frislid; V Hansteen
Journal: Clin Pharmacokinet Date: 1977 May-Jun Impact factor: 6.447

6. Acetylation of serotonin in vitro by a human N-acetyltransferase.

Authors: T A White; J W Jenne; D A Evans
Journal: Biochem J Date: 1969-07 Impact factor: 3.857

7. Drug metabolism by the gastrointestinal mucosa.

Authors: C F George
Journal: Clin Pharmacokinet Date: 1981 Jul-Aug Impact factor: 6.447

8. N-acetylation of drugs. Observations on the properties of partially purified N-acetyltransferase from peripheral blood of rabbit.

Authors: G S Drummond; H C Kelker; W W Weber
Journal: Biochem J Date: 1980-04-01 Impact factor: 3.857

9. Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase.

Authors: D J Hearse; W W Weber
Journal: Biochem J Date: 1973-03 Impact factor: 3.857

Review 10. Arylamine N-acetyltransferases in mycobacteria.

Authors: Edith Sim; James Sandy; Dimitrios Evangelopoulos; Elizabeth Fullam; Sanjib Bhakta; Isaac Westwood; Anna Krylova; Nathan Lack; Martin Noble
Journal: Curr Drug Metab Date: 2008-07 Impact factor: 3.731